Antiatherogenic effects of ellagic acid and urolithins in vitro

Archives of Biochemistry and Biophysics

Volumn 599, Issue , 2016, Pages 42-50

  Mele, Laura ^a   Mena, Pedro ^a   Piemontese, Antonio ^a   Marino, Valentina ^a   López Gutiérrez, Noelia ^b   Bernini, Franco ^a   Brighenti, Furio ^a   Zanotti, Ilaria ^a   Del Rio, Daniele ^a,c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF ALMERÍA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Cholesterol transport; Ellagitannin metabolites; Endothelial function; Peripheral metabolism; Urolithins

Indexed keywords

CHOLESTEROL; ELLAGIC ACID; ELLAGITANNIN; HYPOCHOLESTEROLEMIC AGENT; INTERLEUKIN 6; UNCLASSIFIED DRUG; UROLITHIN A; UROLITHIN B; UROLITHIN C; UROLITHIN D; UROLITHIN DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1; 3,8-DIHYDROXY-6H-DIBENZO(B,D)PYRAN-6-ONE; COUMARIN DERIVATIVE; IL6 PROTEIN, HUMAN; TANNIN;

ANTIATHEROGENIC EFFECT; ARTICLE; CELL ADHESION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; DRUG HYDROXYLATION; DRUG TRANSFORMATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; ATHEROSCLEROSIS; METABOLISM; TUMOR CELL LINE;

ATHEROSCLEROSIS; CELL LINE, TUMOR; CHOLESTEROL; COUMARINS; ELLAGIC ACID; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROLYZABLE TANNINS; INTERLEUKIN-6; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84966534214     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2016.02.017     Document Type: Article

References (43)

1. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 3 2011 341 355
2. H.S. Kruth Fluid-phase pinocytosis of LDL by macrophages: a novel target to reduce macrophage cholesterol accumulation in atherosclerotic lesions Curr. Pharm. Des. 19 33 2013 5865 5872
3. A.J. Lusis Atherosclerosis Nature 407 6801 2000 233 241
4. A. Crozier, I.B. Jaganath, and M.N. Clifford Dietary phenolics: chemistry, bioavailability and effects on health Nat. Prod. Rep. 26 8 2009 1001 1043
5. P. Mena, and et al. Chapter 6-Bioactivation of High-molecular-weight Polyphenols by the Gut Microbiome K.T.D.D. Rio, Diet-microbe Interactions in the Gut 2015 Academic Press San Diego 73 101
6. K.J. Anderson, and et al. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation J. Nutr. 131 11 2001 2837 2842
7. M. Aviram, and et al. Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E 0) mice and in vitro in cultured macrophages and lipoproteins J. Agric. Food Chem. 56 3 2008 1148 1157
8. F. de Nigris, and et al. Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress Proc. Natl. Acad. Sci. U. S. A. 102 13 2005 4896 4901
9. F. de Nigris, and et al. Effects of a pomegranate fruit extract rich in punicalagin on oxidation-sensitive genes and eNOS activity at sites of perturbed shear stress and atherogenesis Cardiovasc Res. 73 2 2007 414 423
10. Z. Papoutsi, and et al. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483 Br. J. Nutr. 99 4 2008 715 722
11. M. Larrosa, and et al. Ellagitannins, ellagic acid and vascular health Mol. Aspects Med. 31 6 2010 513 539
12. I. Zanotti, and et al. Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism Food Funct. 6 1 2015 13 31
13. R. Gonzalez-Barrio, C.A. Edwards, and A. Crozier Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies Drug Metab. Dispos. 39 9 2011 1680 1688
14. J.C. Espín, and et al. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans J. Agric. Food Chem. 55 25 2007 10476 10485
15. A. Gonzalez-Sarrias, and et al. Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice Mol. Nutr. Food Res. 54 3 2010 311 322
16. J.P. Piwowarski, and et al. Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages Mol. Nutr. Food Res. 59 2015 2168 2177
17. J.A. Giménez-Bastida, and et al. Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells Mol. Nutr. Food Res. 56 5 2012 784 796
18. A.V. Khera, and et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2 2011 127 135
19. A. Rohatgi, and et al. HDL cholesterol efflux capacity and incident cardiovascular events N. Engl. J. Med. 371 25 2014 2383 2393
20. R. Sala, and et al. Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions J. Funct. Foods 15 0 2015 97 105
21. S.K. Basu, and et al. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts Proc. Natl. Acad. Sci. U. S. A. 73 9 1976 3178 3182
22. R.E. Brown, K.L. Jarvis, and K.J. Hyland Protein measurement using bicinchoninic acid - elimination of interfering substances Anal. Biochem. 180 1 1989 136 139
23. I. Zanotti, E. Favari, and F. Bernini Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations Curr. Pharm. Biotechnol. 13 2 2012 292 302
24. J. van Meerloo, G.J. Kaspers, and J. Cloos Cell sensitivity assays: the MTT assay Methods Mol. Biol. 731 2011 237 245
25. D.J. Rader, and et al. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis J. Lipid Res. 50 Suppl. 2009 S189 S194
26. M.Y. van der Wulp, H.J. Verkade, and A.K. Groen Regulation of cholesterol homeostasis Mol. Cell Endocrinol. 368 1-2 2013 1 16
27. J.R. Bradley TNF-mediated inflammatory disease J. Pathol. 214 2 2008 149 160
28. M.A. Nunez-Sanchez, and et al. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients Mol. Nutr. Food Res. 58 6 2014 1199 1211
29. F.A. Tomás-Barberán, and et al. Ellagic acid metabolism by human gut microbiota: Consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status J. Agric. Food Chem. 62 28 2014 6535 6538
30. M.I. Cybulsky, and et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis J. Clin. Invest. 107 10 2001 1255 1262
31. V. Videm, and M. Albrigtsen Soluble ICAM-1 and VCAM-1 as markers of endothelial activation Scand. J. Immunol. 67 5 2008 523 531
32. A.G. Kjaergaard, and et al. Soluble adhesion molecules correlate with surface expression in an in vitro model of endothelial activation Basic Clin. Pharmacol. Toxicol. 113 4 2013 273 279
33. W.J. Lee, and et al. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells J. Vasc. Surg. 52 5 2010 1290 1300
34. Y.M. Yu, and et al. Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells Br. J. Nutr. 97 4 2007 692 698
35. S.H. Park, and et al. Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages J. Nutr. 141 11 2011 1931 1937
36. J.L. Goldstein, and M.S. Brown The LDL pathway in human fibroblasts: a receptor-mediated mechanism for the regulation of cholesterol metabolism Curr. Top. Cell Regul. 11 1976 147 181
37. J.L. Goldstein, and M.S. Brown The LDL receptor and the regulation of cellular cholesterol metabolism J. Cell Sci. Suppl. 3 1985 131 137
38. I. Abe, and et al. Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase J. Nat. Prod. 64 8 2001 1010 1014
39. J.P. Piwowarski, and et al. Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials J. Ethnopharmacol. 155 1 2014 801 809
40. J.P. Piwowarski, S. Granica, and A.K. Kiss Influence of gut microbiota-derived ellagitannins metabolites urolithins on pro-inflammatory activities of human neutrophils Planta Med. 80 11 2014 887 895
41. C. Giorgio, and et al. The ellagitannin colonic metabolite urolithin D selectively inhibits EphA2 phosphorylation in prostate cancer cells Mol. Nutr. Food Res. 59 2015 2155 2167
42. L. Dellafiora, and et al. Modelling the possible bioactivity of ellagitannin-derived metabolites. in silico tools to evaluate their potential xenoestrogenic behavior Food Funct. 4 10 2013 1442 1451
43. A. Gonzalez-Sarrias, and et al. Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells Eur. J. Nutr. 53 3 2014 853 864